Intervention

placebo tablet

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting0

Common conditions11

Lead sponsors shown7

Clinical trials

7 shown

Insulin Resistance and Androgen Deprivation TherapyNCT04995978 · 2021-12-01

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of AsthmaNCT01687296 · 2012-11-12

A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and MicroalbuminuriaNCT00843388 · 2009-03-01

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)NCT00637273 · 2008-01-01

Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery DiseaseNCT01574820 · 2006-11-01

Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 DiabetesNCT00898950 · 2004-08-01

The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)NCT00911547 · 1995-03-01

Common conditions

Asthma2 Insulin Resistance2 Blood Pressure1 Coronary Artery Disease1 Diabetes Mellitus1 Diabetes Type 21 Glucose Intolerance1 Nephropathy1 Prediabetes1 Prostate Cancer1 Type 2 Diabetes Mellitus1

Leading sponsors

AstraZeneca1 GlaxoSmithKline1 National Cheng-Kung University Hospital1 Organon and Co1 St. Louis University1 Steno Diabetes Center Copenhagen1 University of Portsmouth1

Trial status mix

COMPLETED5

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE34

NA1

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.